AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20077989 — intervention group
Group type: EXPERIMENTAL
Intervention: Capacity Intervention (improving strength and balance)
Number of subjects: 24
Study 20077989 — intervention group
Group type: EXPERIMENTAL
Intervention: Performance Intervention (fostering daily mobility and activity)
Number of subjects: 24
Study 20077989 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilitating Intervention (providing education, support, and stress management)
Number of subjects: 24
Study 20077989 — intervention group
Group type: EXPERIMENTAL
Intervention: CNRP overall
Number of subjects: 24
Study 17259484 — intervention group
Group type: EXPERIMENTAL
Intervention: Vildagliptin (100 mg daily, divided doses)
Number of subjects: 786
Study 17259484 — intervention group
Group type: COMPARATOR
Intervention: Rosiglitazone (8 mg daily, once daily)
Number of subjects: 786
Study 15634825 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg of methadone
Number of subjects: 65
Study 15634825 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg of morphine
Number of subjects: 65
Study 15634825 — intervention group
Group type: COMPARATOR
Intervention: 0.5 mL of saline solution
Number of subjects: 65
Study 12059047 — intervention group
Group type: EXPERIMENTAL
Intervention: AIT-082 (0.6, 2.0, 6.0, and 20.0 mg/kg)
Number of subjects: 9
Study 12059047 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 10435265 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1
Study 7733089 — intervention group
Group type: EXPERIMENTAL
Intervention: Nipradilol 6 mg twice a day (n = 14)
Number of subjects: 20
Study 7733089 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 6)
Number of subjects: 20
Study 2209498 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic prophylaxis (Cefotaxime 2 g i.v. 15 min before the procedure)
Number of subjects: 96
Study 2209498 — intervention group
Group type: COMPARATOR
Intervention: Control group (no antibiotic prophylaxis)
Number of subjects: 96
Study 2209498 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic prophylaxis
Number of subjects: 96
Study 2209498 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 96
Study 7421359 — intervention group
Group type: EXPERIMENTAL
Intervention: Quinine sulphate (300 mg capsule)
Number of subjects: 21
Study 7421359 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 26787360 — intervention group
Group type: EXPERIMENTAL
Intervention: CALM intervention
Number of subjects: 60
Study 26787360 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 60
Study 28259500 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Check‐up (FCU)
Number of subjects: 92
Study 28259500 — intervention group
Group type: COMPARATOR
Intervention: Psychoeducation (PE)
Number of subjects: 92
Study 25890296 — intervention group
Group type: COMPARATOR
Intervention: PVP (group 1, n=37)
Number of subjects: 68
Study 25890296 — intervention group
Group type: EXPERIMENTAL
Intervention: MIPS combined with PVP (group 2, n=31)
Number of subjects: 68
Study 24063212 — intervention group
Group type: EXPERIMENTAL
Intervention: Tongjiang Granule (TJG), 10 g each time, three times a day for 4 weeks
Number of subjects: 128
Study 24063212 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole Tablet, 20 mg each time, two times a day for 4 weeks
Number of subjects: 128
Study 21370966 — intervention group
Group type: EXPERIMENTAL
Intervention: Coenzyme Q(10) (200 mg/day)
Number of subjects: 51
Study 21370966 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study 21370966 — intervention group
Group type: COMPARATOR
Intervention: Coenzyme Q(10) (200 mg/day) vs Placebo
Number of subjects: 51
Study 19647175 — intervention group
Group type: EXPERIMENTAL
Intervention: Lymphoseek (1.0 nmol)
Number of subjects: 11
Study 19647175 — intervention group
Group type: COMPARATOR
Intervention: Tc-99m-sulfur colloid (TcSC)
Number of subjects: 11
Study 17722619 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal suppositories vitaprost forte
Number of subjects: 0
Study 15104911 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavior therapy (CBT) delivered by videoconference
Number of subjects: 21
Study 15104911 — intervention group
Group type: COMPARATOR
Intervention: Cognitive-behavior therapy (CBT) delivered face-to-face
Number of subjects: 21
Study 11361049 — intervention group
Group type: EXPERIMENTAL
Intervention: GW420867X 100 mg (fasted state)
Number of subjects: 15
Study 11361049 — intervention group
Group type: COMPARATOR
Intervention: GW420867X 100 mg (high-fat meal)
Number of subjects: 15
Study 11361049 — intervention group
Group type: COMPARATOR
Intervention: GW420867X 100 mg (normal fat meal)
Number of subjects: 15
Study 10025066 — intervention group
Group type: EXPERIMENTAL
Intervention: Protective stenting (Palmaz‐Schatz stents) after successful recanalization of TCO
Number of subjects: 100
Study 10025066 — intervention group
Group type: COMPARATOR
Intervention: Conventional PTCA (without protective stenting)
Number of subjects: 100
Study 10025066 — intervention group
Group type: EXPERIMENTAL
Intervention: Protective stenting
Number of subjects: 100
Study 7986784 — intervention group
Group type: EXPERIMENTAL
Intervention: Soymilk
Number of subjects: 8
Study 7986784 — intervention group
Group type: EXPERIMENTAL
Intervention: Concentrated soya-bean-protein solution (isolate)
Number of subjects: 8
Study 7986784 — intervention group
Group type: COMPARATOR
Intervention: Water
Number of subjects: 8
Study 2915537 — intervention group
Group type: EXPERIMENTAL
Intervention: Peripheral vascular patients (N = 15)
Number of subjects: 24
Study 2915537 — intervention group
Group type: COMPARATOR
Intervention: Disease‐free controls (N = 9)
Number of subjects: 24
Study 2915537 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Cases and Controls)
Number of subjects: 24
Study 789380 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (200 milligrams three times a day)
Number of subjects: 100
Study 789380 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 29878264 — intervention group
Group type: EXPERIMENTAL
Intervention: Surfactant lung lavage (SLL)
Number of subjects: 60
Study 29878264 — intervention group
Group type: COMPARATOR
Intervention: No lung lavage (NLL)
Number of subjects: 60
Study 28805759 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-acting pentoxifylline (vasonite) in combined therapy
Number of subjects: 36
Study 26125259 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BTX-A) treatment
Number of subjects: 105
Study 26125259 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BTX-A) treatment combined with orthopedic joint brace
Number of subjects: 105
Study 26125259 — intervention group
Group type: COMPARATOR
Intervention: Oral medications
Number of subjects: 105
Study 23042612 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) - seven individual sessions concurrent with radiotherapy
Number of subjects: 35
Study 23042612 — intervention group
Group type: COMPARATOR
Intervention: Non-directive supportive counseling (SC) - seven individual sessions concurrent with radiotherapy
Number of subjects: 35
Study 21705562 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicruciate-stabilised TKR
Number of subjects: 28
Study 21705562 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior-stabilised TKR
Number of subjects: 28
Study 21705562 — intervention group
Group type: COMPARATOR
Intervention: Pre-operative knees
Number of subjects: 28
Study 21705562 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 28
Study 18851851 — intervention group
Group type: EXPERIMENTAL
Intervention: Quantitative index (QI; 0-10)
Number of subjects: 40
Study 18851851 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative evaluation (QE; poor, fair, good, excellent)
Number of subjects: 40
Study 18851851 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall adequacy assessment (OAA; inadequate, adequate)
Number of subjects: 40
Study 16462661 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefpodoxime-proxetil (200 mg bid for 5 days)
Number of subjects: 512
Study 16462661 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin-clavulanic acid (1 g/125 mg bid for 8 days)
Number of subjects: 512
Study 16462661 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefpodoxime-proxetil
Number of subjects: 512
Study 16462661 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin-clavulanic acid
Number of subjects: 512
Study 15586136 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing intervention
Number of subjects: 137
Study 15586136 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 137
Study 11760163 — intervention group
Group type: COMPARATOR
Intervention: Ceftazidime (2 g t.i.d.) + Amikacin (15 mg/kg/o.d.)
Number of subjects: 208
Study 11760163 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefepime (2 g b.i.d.) + Amikacin (15 mg/kg/o.d.)
Number of subjects: 208
Study 9289668 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge of Mediterranean anemia
Number of subjects: 124
Study 9289668 — intervention group
Group type: EXPERIMENTAL
Intervention: Discussion with doctor about Mediterranean anemia
Number of subjects: 124
Study 9289668 — intervention group
Group type: EXPERIMENTAL
Intervention: Discussion with gynecologist about Mediterranean anemia
Number of subjects: 124
Study 9289668 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge of hemoglobinophoresis
Number of subjects: 124
Study 9289668 — intervention group
Group type: EXPERIMENTAL
Intervention: Awareness of hemoglobinophoresis test
Number of subjects: 124
Study 9289668 — intervention group
Group type: EXPERIMENTAL
Intervention: Informed about Mediterranean anemia before age 20
Number of subjects: 124
Study 9289668 — intervention group
Group type: EXPERIMENTAL
Intervention: Informed about Mediterranean anemia between ages 20 and 35
Number of subjects: 124
Study 9289668 — intervention group
Group type: EXPERIMENTAL
Intervention: Correct response to risk of severe blood pathology in carriers
Number of subjects: 124
Study 8358903 — intervention group
Group type: EXPERIMENTAL
Intervention: Collared prostheses
Number of subjects: 84
Study 8358903 — intervention group
Group type: COMPARATOR
Intervention: Collarless prostheses
Number of subjects: 84
Study 8358903 — intervention group
Group type: EXPERIMENTAL
Intervention: Collared prostheses with poor bone contact
Number of subjects: 84
Study 8358903 — intervention group
Group type: EXPERIMENTAL
Intervention: Collared prostheses with good bone contact
Number of subjects: 84
Study 8358903 — intervention group
Group type: COMPARATOR
Intervention: Collarless group
Number of subjects: 84
Study 8358903 — intervention group
Group type: EXPERIMENTAL
Intervention: Collared group
Number of subjects: 84
Study 8358903 — intervention group
Group type: EXPERIMENTAL
Intervention: Collared and collarless prostheses
Number of subjects: 84
Study 3085430 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfentanil 15 micrograms/kg
Number of subjects: 10
Study 3085430 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 3085430 — intervention group
Group type: COMPARATOR
Intervention: Diazepam 5 mg
Number of subjects: 10
Study 3085430 — intervention group
Group type: COMPARATOR
Intervention: Droperidol 5 mg
Number of subjects: 10
Study 3085430 — intervention group
Group type: COMPARATOR
Intervention: Etomidate 10 mg
Number of subjects: 10
Study 29783091 — intervention group
Group type: EXPERIMENTAL
Intervention: MIND-S (home-based dementia care coordination)
Number of subjects: 304
Study 29783091 — intervention group
Group type: COMPARATOR
Intervention: Augmented usual care group
Number of subjects: 304
Study 26487578 — intervention group
Group type: EXPERIMENTAL
Intervention: LV5FU2
Number of subjects: 282
Study 26487578 — intervention group
Group type: EXPERIMENTAL
Intervention: LV5FU2-irinotecan
Number of subjects: 282
Study 26487578 — intervention group
Group type: COMPARATOR
Intervention: simplified LV5FU2
Number of subjects: 282
Study 26487578 — intervention group
Group type: COMPARATOR
Intervention: FOLFIRI
Number of subjects: 282
Study 24980836 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week yoga intervention (n=15), consisting of a weekly 90-minute teacher-led class and a 40-minute daily session delivered by DVD
Number of subjects: 28
Study 24980836 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week yoga intervention (n=15)
Number of subjects: 28
Study 24980836 — intervention group
Group type: COMPARATOR
Intervention: Usual care wait-listed control group (n=13)
Number of subjects: 28
Study 23268423 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic ventriculoperitoneal shunt with temporary external drainage
Number of subjects: 52
Study 23268423 — intervention group
Group type: COMPARATOR
Intervention: Conventional ventriculoperitoneal shunt
Number of subjects: 52
Study 20723019 — intervention group
Group type: EXPERIMENTAL
Intervention: Simplified technique (S)
Number of subjects: 122
Study 20723019 — intervention group
Group type: COMPARATOR
Intervention: Traditional academic standard (T)
Number of subjects: 122
Study 19071990 — intervention group
Group type: EXPERIMENTAL
Intervention: Salient distractor in visual search with highly similar target and distractors
Number of subjects: 0
Study 19071990 — intervention group
Group type: EXPERIMENTAL
Intervention: Salient distractor in visual search with highly dissimilar target and distractors
Number of subjects: 0
Study 16150255 — intervention group
Group type: EXPERIMENTAL
Intervention: Human papillomavirus deoxyribonucleic acid testing by general primer 5+/6+ polymerase chain reaction
Number of subjects: 12527
Study 16150255 — intervention group
Group type: COMPARATOR
Intervention: Mock testing
Number of subjects: 12527
Study 14716420 — intervention group
Group type: EXPERIMENTAL
Intervention: Hapavax-Gene vaccine (10 microgram doses for ages 10-19, 20 microgram doses for ages over 19) administered intramuscularly in three doses: day 0, after 30 days, and after 180 days.
Number of subjects: 67
Study 11774102 — intervention group
Group type: EXPERIMENTAL
Intervention: HP-CVVH (Continuous Venovenous Hemofiltration)
Number of subjects: 80
Study 11774102 — intervention group
Group type: COMPARATOR
Intervention: HP (Hemoperfusion)
Number of subjects: 80
Study 9723053 — intervention group
Group type: EXPERIMENTAL
Intervention: Dissecting microscope
Number of subjects: 41
Study 9723053 — intervention group
Group type: COMPARATOR
Intervention: Magnifying loupes with transillumination
Number of subjects: 41
Study 8155439 — intervention group
Group type: EXPERIMENTAL
Intervention: suxamethonium 1.5 mg kg‐1
Number of subjects: 80
Study 8155439 — intervention group
Group type: COMPARATOR
Intervention: alfentanil 15 micrograms kg‐1
Number of subjects: 80
Study 3345041 — intervention group
Group type: EXPERIMENTAL
Intervention: Bradykinin challenge
Number of subjects: 8
Study 3345041 — intervention group
Group type: COMPARATOR
Intervention: Placebo challenge
Number of subjects: 8
Study 31278095 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group performing a 12-week, supervised, high-intensity interval training programme (3 sessions/week for 28-40 min/session)
Number of subjects: 66
Study 31278095 — intervention group
Group type: COMPARATOR
Intervention: Usual care group
Number of subjects: 66
Study 27779368 — intervention group
Group type: EXPERIMENTAL
Intervention: Active group (peripheral nerve stimulation of the occipital nerves)
Number of subjects: 20
Study 26031301 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium Hydroxide
Number of subjects: 44
Study 26031301 — intervention group
Group type: EXPERIMENTAL
Intervention: MTA
Number of subjects: 44
Study 26031301 — intervention group
Group type: EXPERIMENTAL
Intervention: Biodentine
Number of subjects: 44
Study 26031301 — intervention group
Group type: COMPARATOR
Intervention: Single Bond Universal
Number of subjects: 44
Study 23273365 — intervention group
Group type: EXPERIMENTAL
Intervention: Transbond LR composite paste without liquid resin (test group)
Number of subjects: 40
Study 23273365 — intervention group
Group type: COMPARATOR
Intervention: Transbond LR composite paste with liquid resin (control group)
Number of subjects: 40
Study 23273365 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study 23273365 — intervention group
Group type: EXPERIMENTAL
Intervention: Test group
Number of subjects: 40
Study 21787487 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP)
Number of subjects: 30
Study 21787487 — intervention group
Group type: EXPERIMENTAL
Intervention: PRP + collagen sponge
Number of subjects: 30
Study 21787487 — intervention group
Group type: COMPARATOR
Intervention: Collagen membrane (GTR)
Number of subjects: 30
Study 20112574 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxibustion
Number of subjects: 65
Study 20112574 — intervention group
Group type: COMPARATOR
Intervention: Infrared therapy
Number of subjects: 65
Study 17322819 — intervention group
Group type: EXPERIMENTAL
Intervention: Schools with iodinator
Number of subjects: 1100
Study 17322819 — intervention group
Group type: COMPARATOR
Intervention: Schools without iodinator
Number of subjects: 1100
Study 15306594 — intervention group
Group type: EXPERIMENTAL
Intervention: PhiCal test (calprotectin level > or =50 microg/g)
Number of subjects: 2321
Study 15306594 — intervention group
Group type: COMPARATOR
Intervention: FlexSure OBT (human haemoglobin immunochemical FOBT)
Number of subjects: 2321
Study 15306594 — intervention group
Group type: EXPERIMENTAL
Intervention: PhiCal test
Number of subjects: 2321
Study 15306594 — intervention group
Group type: COMPARATOR
Intervention: FlexSure OBT
Number of subjects: 2321
Study 11283130 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy (5 x 5 Gy)
Number of subjects: 1321
Study 11283130 — intervention group
Group type: COMPARATOR
Intervention: TME surgery alone
Number of subjects: 1321
Study 9709267 — intervention group
Group type: EXPERIMENTAL
Intervention: Mammography screening
Number of subjects: 0
Study 8292066 — intervention group
Group type: EXPERIMENTAL
Intervention: Compressed naproxen suppositories (250 mg)
Number of subjects: 12
Study 8292066 — intervention group
Group type: COMPARATOR
Intervention: Standard naproxen tablet
Number of subjects: 12
Study 30955977 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab 200 mg every 3 weeks for up to 35 cycles
Number of subjects: 1274
Study 30955977 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy (investigator's choice of platinum-based chemotherapy for four to six cycles)
Number of subjects: 1274
Study 26924360 — intervention group
Group type: EXPERIMENTAL
Intervention: O-(beta-Hydroxyethyl)-rutosides (Oxerutin), 500 mg po q12hr
Number of subjects: 60
Study 26924360 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 60
Study 26252342 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined resistance and endurance training (REG)
Number of subjects: 36
Study 26252342 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training alone (RG)
Number of subjects: 36
Study 26252342 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 36
Study 23004225 — intervention group
Group type: EXPERIMENTAL
Intervention: Nerve stimulation (Group NS)
Number of subjects: 60
Study 23004225 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound guidance (Group US)
Number of subjects: 60
Study 22035463 — intervention group
Group type: EXPERIMENTAL
Intervention: Aliskiren 150 mg once daily
Number of subjects: 1955
Study 22035463 — intervention group
Group type: EXPERIMENTAL
Intervention: Aliskiren 300 mg once daily
Number of subjects: 1955
Study 22035463 — intervention group
Group type: EXPERIMENTAL
Intervention: Aliskiren 300 mg once daily + HCTZ 12.5 mg once daily
Number of subjects: 1955
Study 22035463 — intervention group
Group type: EXPERIMENTAL
Intervention: Aliskiren 300 mg once daily + HCTZ 25 mg once daily
Number of subjects: 1955
Study 22035463 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 1955
Study 18465710 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta‐RT (90Sr eye applicator delivering 2500 cGy)
Number of subjects: 81
Study 18465710 — intervention group
Group type: COMPARATOR
Intervention: Sham irradiation (same applicator without 90Sr)
Number of subjects: 81
Study 18465710 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta‐RT
Number of subjects: 81
Study 18465710 — intervention group
Group type: COMPARATOR
Intervention: Sham irradiation
Number of subjects: 81
Study 17211296 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 ppb ozone
Number of subjects: 0
Study 14651394 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital rectal examination
Number of subjects: 1225
Study 14651394 — intervention group
Group type: EXPERIMENTAL
Intervention: PSA test
Number of subjects: 1225
Study 14651394 — intervention group
Group type: COMPARATOR
Intervention: Digital rectal examination or PSA test
Number of subjects: 1225
Study 11089748 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% chlorhexidine gel, three times a day during the ICU stay
Number of subjects: 60
Study 11089748 — intervention group
Group type: COMPARATOR
Intervention: Standard oral care
Number of subjects: 60
Study 9352276 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac sodium 0.1% ophthalmic solution
Number of subjects: 116
Study 9352276 — intervention group
Group type: COMPARATOR
Intervention: Prednisolone acetate 1.0% ophthalmic suspension
Number of subjects: 116
Study 8452179 — intervention group
Group type: EXPERIMENTAL
Intervention: Fleroxacin (400 mg) given as a single dose
Number of subjects: 508
Study 8452179 — intervention group
Group type: EXPERIMENTAL
Intervention: Fleroxacin (400 mg) given once daily for 3 days
Number of subjects: 508
Study 8452179 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 508
Study 3940260 — intervention group
Group type: EXPERIMENTAL
Intervention: Loperamide (12 mg)
Number of subjects: 9
Study 3940260 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 31744020 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided central line insertion (US-guided CICC)
Number of subjects: 61
Study 31744020 — intervention group
Group type: COMPARATOR
Intervention: Peripherally inserted catheter (PICC)
Number of subjects: 61
Study 29800622 — intervention group
Group type: EXPERIMENTAL
Intervention: UC + CALM ARC
Number of subjects: 75
Study 29800622 — intervention group
Group type: COMPARATOR
Intervention: UC
Number of subjects: 75
Study 27082519 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal oxygen insufflation (100 mL/kg/min, estimated 37% FiO2, n = 9)
Number of subjects: 19
Study 27082519 — intervention group
Group type: COMPARATOR
Intervention: Room air (estimated 21% FiO2, n = 10)
Number of subjects: 19